1. Home
  2. AUPH vs ALGT Comparison

AUPH vs ALGT Comparison

Compare AUPH & ALGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AUPH
  • ALGT
  • Stock Information
  • Founded
  • AUPH 1993
  • ALGT 1997
  • Country
  • AUPH Canada
  • ALGT United States
  • Employees
  • AUPH N/A
  • ALGT N/A
  • Industry
  • AUPH Biotechnology: Pharmaceutical Preparations
  • ALGT Air Freight/Delivery Services
  • Sector
  • AUPH Health Care
  • ALGT Consumer Discretionary
  • Exchange
  • AUPH Nasdaq
  • ALGT Nasdaq
  • Market Cap
  • AUPH 1.4B
  • ALGT 1.1B
  • IPO Year
  • AUPH 1999
  • ALGT 2006
  • Fundamental
  • Price
  • AUPH $12.74
  • ALGT $64.74
  • Analyst Decision
  • AUPH Strong Buy
  • ALGT Hold
  • Analyst Count
  • AUPH 3
  • ALGT 9
  • Target Price
  • AUPH $12.00
  • ALGT $66.56
  • AVG Volume (30 Days)
  • AUPH 1.6M
  • ALGT 363.5K
  • Earning Date
  • AUPH 11-06-2025
  • ALGT 10-29-2025
  • Dividend Yield
  • AUPH N/A
  • ALGT N/A
  • EPS Growth
  • AUPH N/A
  • ALGT N/A
  • EPS
  • AUPH 0.42
  • ALGT N/A
  • Revenue
  • AUPH $260,111,000.00
  • ALGT $2,578,359,000.00
  • Revenue This Year
  • AUPH $16.92
  • ALGT $5.83
  • Revenue Next Year
  • AUPH $14.43
  • ALGT $5.94
  • P/E Ratio
  • AUPH $30.31
  • ALGT N/A
  • Revenue Growth
  • AUPH 25.59
  • ALGT 3.17
  • 52 Week Low
  • AUPH $6.43
  • ALGT $39.80
  • 52 Week High
  • AUPH $12.87
  • ALGT $107.57
  • Technical
  • Relative Strength Index (RSI)
  • AUPH 68.02
  • ALGT 62.05
  • Support Level
  • AUPH $12.06
  • ALGT $60.00
  • Resistance Level
  • AUPH $12.82
  • ALGT $67.34
  • Average True Range (ATR)
  • AUPH 0.37
  • ALGT 2.76
  • MACD
  • AUPH -0.05
  • ALGT -0.05
  • Stochastic Oscillator
  • AUPH 90.00
  • ALGT 68.18

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

About ALGT Allegiant Travel Company

Allegiant Travel Co is a leisure travel company focused on providing travel and leisure services and products to residents of under-served cities in the United States. It operates a low-cost, low utilization passenger airline marketed to leisure travelers in under-served cities, allowing it to sell air transportation both on a stand-alone basis and bundled with the sale of air-related and third-party services and products. In addition, it provides air transportation under fixed-fee flight arrangements. In connection with its leisure travel focus, the company has opened Sunseeker Resort Charlotte Harbor, equipped with several guestrooms and food and beverage outlets. The company's operating segments are the Airline, which generates maximum revenue, and Sunseeker Resort.

Share on Social Networks: